Zobrazeno 1 - 10
of 179
pro vyhledávání: '"Soler Roselló A"'
Autor:
Soler Roselló, Jorge
Publikováno v:
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
instname
Consulta en la Biblioteca ETSI Industriales (6443)
[ES] El objeto es realizar el proyecto de la una planta destinada a la fabricación de muebles de cocina, para ello se estudia el proceso productivo a desarrollar en la planta, a partir de él s
[ES] El objeto es realizar el proyecto de la una planta destinada a la fabricación de muebles de cocina, para ello se estudia el proceso productivo a desarrollar en la planta, a partir de él s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a37cb8693ccb4be8129d0088057e1c75
http://hdl.handle.net/10251/35752
http://hdl.handle.net/10251/35752
Autor:
J, Morote, C, Vallejo, J A, Lorente, G, Encabo, M A, López Pacios, J A, de Torres, A, Soler Roselló
Publikováno v:
Actas urologicas espanolas. 19(8)
Of 102 patients with metastatic prostate cancer, 52 were treated with orchidectomy and 50 with CHB; 22 of these received a LHRH analog + Flutamide and 28 orchidectomy + Flutamide. No differences were seen in either arm in terms of age (69.9 vs 70.2 y
Autor:
C, Vallejo Gil, E V, Palacio, C, Reig Ruiz, C, Raventos Busquets, J, Morote Robles, A, Soler Roselló
Publikováno v:
Actas urologicas espanolas. 18(8)
Atraumatic spontaneous vesical fracture is an uncommon occurrence. Here we present the case of a female patient with spontaneous vesical fracture secondary to urinary tract tuberculosis. A review of current literature showed another published case si
Autor:
C, Vallejo Gil, D, García Rojo, J M, Banús Gassol, V, Fernández, M, Muniesa Caldero, A, Soler Roselló
Publikováno v:
Actas urologicas espanolas. 18(7)
Presentation of one case of obstructive anuria secondary to perianeurysmal retroperitoneal fibrosis (PRF). Diagnosis was confirmed by abdominal ultrasound and CAT. The condition's initial treatment consisted in bilateral percutaneous nephrostomy. Fol
Autor:
J, Morote, J A, Lorente, C, Vallejo, G, Encabo, M A, López-Pacios, J A, De Torres, A, Soler Roselló
Publikováno v:
Actas urologicas espanolas. 18(6)
A total of 110 patients with hormone-treated metastatic prostate cancer were monitored quarterly with serial PSA determinations. At the first control, 6 patients had progressed clinically, 5 of which had decreased PSA ranging between 9-77%. After a p
Publikováno v:
Actas urologicas espanolas. 18(6)
Presentation of one case of a patient with vesical sarcoma with sustained high white blood cells and platelets plasma levels over the course of the disease. In the absence of fever and with a persistently negative blood culture, the situation was rat
Autor:
C, Reig Ruiz, C, Vallejo Gil, J A, Lorente Garín, J, Vila Barja, J, Morote Robles, A, Soler Roselló
Publikováno v:
Actas urologicas espanolas. 18(5)
Exposition of one case of vesico-ileal fistula with atypical presentation and infrequent etiology, secondary to transitional cell vesical carcinoma. The incident is exploited to review the etiology of acquired enterovesical fistulae.
Publikováno v:
Actas urologicas espanolas. 18(5)
The inversion of PSA/PAP ratio is not common in patients with prostate cancer. Of 215 patients, 7 showed PSA levels below those of PAP (3.2%). All patients had metastatic disease at the time of diagnosis, 57% in multiple organs and tissues, with a Gl
Autor:
C, Reig Ruíz, J, Morote Robles, J A, Lorente Garín, J I, Idoipe Tomás, M A, López Pacios, J A, de Torres Mateos, A, Soler Roselló
Publikováno v:
Archivos espanoles de urologia. 46(9)
Patients on anticoagulant therapy may develop urologic complications, the most common being hematuria. Other less common but more severe complications are spontaneous hemorrhage arising from urological structures, as spontaneous perirenal hematoma, o
Autor:
J, Morote Robles, C, Reig Ruiz, J, Vila Barja, M A, López Pacios, J A, de Torres Mateos, A, Soler Roselló
Publikováno v:
Actas urologicas espanolas. 17(5)
Analysis of the evolution of 78 patients with hormonally-treated non-metastatic prostate cancer. During an average follow-up of 62.3 months, local clinical and metastatic progression in 14.1% and 7.7% cases, respectively, was observed. Overall, PSA d